TSC2
About
Location: 16p13.3
Mappings
Biomarkers
TSC2 is involved in the following curated biomarkers.
| Name | Biomarker type | Propositions | Statements |
|---|---|---|---|
| TSC2 oncogenic variants | Somatic Variant | 2 | 2 |
Therapeutic response
Precision oncology relationships for therapeutic response involving this gene.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | TSC2 oncogenic variants | Renal Angiomyolipoma | Everolimus | |
| FDA (1) | TSC2 oncogenic variants | Anaplastic Thyroid Cancer | Everolimus |